NEVRO CORP. Payment for Contingent Consideration Liability, Operating Activities
NEVRO CORP. reported Payment for Contingent Consideration Liability, Operating Activities of $5.04 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities · last filed 2025-03-04
- NEVRO CORP. payment for contingent consideration liability, operating activities for fiscal 2024 was $5.04M.
- NEVRO CORP. payment for contingent consideration liability, operating activities for fiscal 2023 was $0.00.
- NEVRO CORP. payment for contingent consideration liability, operating activities for fiscal 2022 was $0.00.
| Period end | Payment for Contingent Consideration Liability, Operating Activities 12 month |
|---|---|
| 2024-12-31 | $5.04M 10-K · filed 2025-03-04 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-04 |
| 2022-12-31 | $0.00 10-K · filed 2025-03-04 |